NXTC Projected Dividend Yield
NextCure Inc ( NASDAQ : NXTC )NextCure, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on advancing medicines that treat cancer patients that do not respond to, or have disease progression on, current therapies, through the use of differentiated mechanisms of actions including Antibody-Drug Conjugates (ADCs), antibodies, and proteins. Co. focuses on advancing therapies that leverage its core strengths in understanding biological pathways and biomarkers, the interactions of cells, including in the tumor microenvironment, and the role each interaction plays in a biologic response. Its product candidates include NC410 and LNCB74. Its Clinical Oncology Programs are NC525 and NC318. 21 YEAR PERFORMANCE RESULTS |
NXTC Dividend History Detail NXTC Dividend News NXTC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |